Emergent BioSolutions (STU:ER4) Beginning Cash Position : €103 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Emergent BioSolutions Beginning Cash Position?

Emergent BioSolutions's Beginning Cash Position for the quarter that ended in Mar. 2024 was €103 Mil.

Emergent BioSolutions's quarterly Beginning Cash Position declined from Sep. 2023 (€83 Mil) to Dec. 2023 (€81 Mil) but then increased from Dec. 2023 (€81 Mil) to Mar. 2024 (€103 Mil).

Emergent BioSolutions's annual Beginning Cash Position declined from Dec. 2021 (€550 Mil) to Dec. 2022 (€544 Mil) but then increased from Dec. 2022 (€544 Mil) to Dec. 2023 (€589 Mil).

Emergent BioSolutions Beginning Cash Position Historical Data

The historical data trend for Emergent BioSolutions's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent BioSolutions Beginning Cash Position Chart

Emergent BioSolutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

101.16

138.10

550.03

544.03

589.26

Emergent BioSolutions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															597.76	399.48	83.02	80.51	102.76

Emergent BioSolutions Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Emergent BioSolutions Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Emergent BioSolutions's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Emergent BioSolutions (STU:ER4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent BioSolutions Inc (STU:ER4) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

EBS:USA ER4:Germany

Address

400 Professional Drive, Suite 400, Gaithersburg, MD, USA, 20879

Website

https://www.emergentbiosolutions.com

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.

Emergent BioSolutions (STU:ER4) Headlines

No Headlines